Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern

The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.

from NYT > Health https://ift.tt/3lJ1fC1
via health&fitness